Jeremy Grantham: 9 Amedisys transactions (GMO Asset Management / AMED)

9 Jeremy Grantham Amedisys Trades

The first Amedisys trade was made in Q1 2020. Since then Jeremy Grantham bought shares four more times and sold shares on four occasions. The investor sold all their shares in Q2 2025 and doesn't own any shares in Amedisys anymore.

Avg closing price

Price range

Sold -164k shares Q2 2025

Avg closing price $94.61

Price range $91.31 - $98.39

New holding (+164k shares) Q1 2025

Avg closing price $92.20

Price range $90.44 - $92.90

Sold -142k shares Q4 2024

Avg closing price $91.69

Price range $83.52 - $97.71

New holding (+142k shares) Q3 2024

Avg closing price $97.57

Price range $96.51 - $98.45

Sold -315k shares Q4 2023

Avg closing price $93.40

Price range $91.15 - $95.90

Increased shares by 215.9% (+215k shares) Q3 2023

Avg closing price $92.41

Price range $89.84 - $94.08

New holding (+99.7k shares) Q2 2023

Avg closing price $82.04

Price range $73.99 - $92.60

Sold -7.3k shares Q2 2020

Avg closing price $186.51

Price range $169.77 - $213.81

New holding (+7.3k shares) Q1 2020

Avg closing price $177.91

Price range $137.21 - $202.02

Never miss a trade

早乙女迅雷

Jeremy Grantham Amedisys Inc.

Current Value of Holding

Shares

% of Portfolio

Average Buy Price

9 Jeremy Grantham Amedisys Trades

早乙女迅雷

Jeremy Grantham Amedisys Inc.

9 Jeremy Grantham Amedisys Trades

Embed chart